Purchase Order 75N95025P00331
- Not listed
- The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $80,650.96 firm fixed price purchase order contract to Revvity Health Sciences, Inc. for the procurement of a MicroBeta2 plate reader and a cell harvester. The contract has a period of performance through July 29, 2021. This purchase supports NIDA's research and development efforts in brain receptor imaging and investigating promising compounds. The award did not utilize any small business set-aside. Revvity Health...
- Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) was awarded a $214,111 firm fixed-price purchase order by the National Institute on Drug Abuse (NIDA) to provide maintenance support services for a Quantum GX MicroCT scanner during option period 3 of an existing contract. The work will be performed at the agency's facility in Bethesda, Maryland, with an ultimate completion date of March 31, 2023. This award represents a non-set-aside contract and reflects NIDA's continued...
- This firm fixed-price delivery order was awarded to Revvity Health Sciences, Inc. by the National Institute on Drug Abuse (NIDA), a civilian agency of the U.S. federal government. The contract, valued at $106,514.11, is for the provision of a MicroBeta 2 plate reader with 6 detectors. It was awarded under the General Services Administration's (GSA) Scientific Equipment and Services schedule (FSS-66) and does not utilize any set-aside designation. Revvity Health Sciences is a for-profit...
- This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services (HHS), to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) on September 26, 2016. The contract has a ceiling value of $320,095.60 and a completion date of January 30, 2017. The contract was not set aside for any specific business type. Revvity Health Sciences, a for-profit manufacturer, will provide medical...
- The National Institute on Drug Abuse awarded a $10,452.85 firm fixed-price purchase order to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) on September 10, 2020, for the procurement of PerkinElmer AlphaLISA acceptor and donor beads. The contract was executed without a small business set-aside designation and is scheduled for completion by October 10, 2020. Performance will take place in Shelton, Connecticut. AlphaLISA beads are critical reagents used in high-throughput...
- Revvity Health Sciences, Inc., a division of Revvity Inc. Medical Imaging, LLC, has been awarded a $17,667 firm fixed price purchase order by the National Institutes of Health's National Institute on Drug Abuse to provide a one-year service agreement for a MicroBeta2 system with six detectors. The service agreement covers the period of September 24, 2023 through September 23, 2024 and will support the Department of Health and Human Services' biomedical research efforts at its Baltimore, Maryland...
- This is a firm-fixed-price purchase order awarded to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.), a for-profit manufacturer of medical imaging products, laboratory equipment, and scientific instrumentation. The contract, valued at $11,322.28, was awarded by the National Institute on Drug Abuse, a civilian agency, to support ongoing binding experiments to study newly emerging drugs of abuse using [3H] DAMGO, [3H] ENKEPHALIN, and [3H] U69,593. The contract does not have a...
- This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) for a multimodal plate reader. The award has a ceiling value of $75,421.69 and an ultimate completion date of March 3, 2017. The contract does not have a set-aside designation. Revvity Health Sciences, Inc. is a for-profit manufacturer of medical imaging...
- This federal contract award is to Revvity Health Sciences, Inc. for the delivery of a HTRF GTP GI Bind. Kit - 20K PTS to the National Institute on Drug Abuse (NIDA), a civilian agency under the U.S. Department of Health and Human Services. The contract has a firm fixed price of $20,727.50 and a period of performance through November 29, 2024. This award is not associated with a set-aside program. Revvity Health Sciences is a for-profit organization that manufactures medical imaging products...
- This federal contract award, with ID 75N95024P00442, is a service agreement for a MicroBeta2 instrument with 6 detectors. The period of performance is from September 24, 2024 to September 23, 2025, with a ceiling value of $19,227.00. The contract was awarded to Revvity Health Sciences, Inc., a for-profit manufacturer of medical imaging products and services that provides equipment and support to various federal agencies like the National Institutes of Health (NIH), Centers for Disease Control...
The National Institute on Drug Abuse (NIDA) awarded a $20,929 firm fixed-price purchase order to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) on September 24, 2025, for a service agreement on a MicroBeta 2 scintillation counter. The contract, which extends through September 23, 2026, is designed to maintain the instrument in working condition at the Drug Dynamics Research Unit (DDRU) and Medicinal and Therapeutic Macromolecules Branch (MTMB) in Baltimore, Maryland, preventing delays in experimental plate processing. No small business set-aside was utilized for this procurement. Revvity Health Sciences is an established large business contractor specializing in scientific instrumentation, laboratory equipment, and maintenance services for federal research agencies. The company maintains an extensive portfolio of contracts across the National Institutes of Health, CDC, and other civilian agencies, providing equipment maintenance, preventative services, and repair support. This purchase order represents a straightforward service engagement supporting NIDA's ongoing laboratory operations and research infrastructure needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.9k | 7/24/25 |